1. Market Research
  2. > Pharmaceutical Market Trends
Transdermal Skin Patches Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Transdermal Skin Patches Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • April 2021
  • 113 pages
  • ID: 6062860
  • Format: PDF
  • Mordor Intelligence LLP
Up to $750 off Until Sep 30th 2021

Summary

Table of Contents

Search Inside

The Transdermal Skin Patches market is expected to register a CAGR of about 4.78% during the forecast period with a revenue of approximately USD 7244.33 million in 2020 and expected to reach USD 9572.34 million by 2026.

The COVID-19 outbreak across the world is expected to have a positive impact on the transdermal skin patches market, as these patches enable safe, reproducible, and controlled administration of drugs to defined skin microenvironment. Therefore, researchers working on a potential vaccine against the new COVID-19 strain causing the pandemic are exploring the use of a fingertip-sized skin patch for delivery.

The major factors attributing to the growth of the market is the increasing advantages of transdermal medicine over oral and ingesting medications (medications for gastrointestinal toxicity) that result in nausea and vomiting. As they are non-invasive in nature, they decrease the inconvenience caused by intravenous or parenteral therapies. The main advantage is that the patch provides a controlled release of the drug to the patient, usually through a perforated membrane covering the drug reservoir or by body temperature dissolving thin layers of medication embedded in the adhesive. These patches are also used for the treatment of migraine, hormones, pain, cardiovascular diseases, neurology disease, and smoking cessation. In current scenario, transdermal route of drug delivery system is increasing in demand due to reduced dosing frequency, improved bioavailability, reduced adverse events, and drug input termination at any point by the removal of the patch.

Furthermore, the growing funding and investments for drug development and new launches boosts the market growth. For instance, in February 2020, the US FDA approved the Contraceptive Patch known has Twirla (levonorgestrel and Ethinylestradiol) Transdermal System, it is a New Weekly Contraceptive Patch from the company, Agile Therapeutics Inc.. Hence, a significant number of clinical trials of different types of drugs is currently underway, and it is likely to positively impact the market in the future.

However, the inability of the skin to absorb a range of active substances is expected to hinder the growth of the market.

Key Market Trends
Smoking Reduction and Cessation Aid Segment is Expected to Grow at High CAGR in the Forecast Period.

According to WHO, 2020, COVID-19 is a disease that primarily attacks the lungs. Smoking damages lung function and makes it harder for the body to fight off coronaviruses and other infections. Therefore, during the pandemic, there is increasing campaigning and awareness about smoking cessation and that increased the segment growth.

The growth rate of the segment is attributed to a large number of smokers globally, and increasing awareness of the advantages of the transdermal route of administration of drugs for smoking cessation. According to the World Health Organization, 8 million people die each year as a result of smoking. More than 7 million deaths are the result of direct tobacco use and an estimated 1.2 million are the result of nonsmokers smoking cigarettes. According to the Centers for Disease Control and Prevention, in 2018, approximately 14 out of 100 U.S. adults 18 years of age or older currently smoke cigarettes, meaning that about 34.2 million adults in the United States currently smoke. About 16 million Americans live with a smoking-related disease. In addition, according to the American Cancer Society Inc., 2019, approximately 942 million men and 175 million women aged 15 or older are active smokers worldwide.

Therefore, with the increasing number of smokers across the world, the usage of the transdermal skin patches (nicotine) is expected to rise in the forecast period, and the rising number of patients is expected to boost the market studied. ?

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to hold the highest share throughout the forecast period. The growth is expected to be augmented by the factors, such as the presence of key players and established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase the market’s growth.

In this region, the United States has the maximum share due to supportive healthcare policies, the high number of patients, and a developed healthcare market. As per the CDC, in 2018, approximately 14 of every 100 US adults aged 18 years and above-smoked cigarettes. This means it was estimated of about 34.2 million adults in the United States currently smoke cigarettes. Technologies supporting transdermal patches are being enhanced uninterruptedly to make them more versatile and popular in the United States. Major companies in the market are increasingly opting for acquisitions and collaborations to enhance and expand their footprint for the growth of the transdermal skin patches market. For instance, in 2019, Canoa Inc., a Delaware-based healthcare and pharmaceuticals company, had acquired ProSolus Inc. to enhance its position and development of new products in the transdermal space.

In 2019, it has been found that in Canada, there are around 100 people that die every day from tobacco smoking-related illness, according to Health Canada. This has increased the widespread availability of drugs, and the advent of new innovative drugs such as transdermal patches has accelerated the pace of growth in the market studied.?

Competitive Landscape
The transdermal skin patches market is moderately competitive and the key players are focused on the adoption of various strategies such as product innovation, product launches, and approvals, R&D investment for advancements in transdermal patches, merger and acquisition as their developmental strategies to sustain the competitive environment in the market. Some of the companies which are currently gaining attention in the market are Teva Pharmaceuticals USA Inc., Novartis AG, Teikoku Pharma USA Inc., Mylan Inc., 3M.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off

$4250

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Middle East & Africa Custom Antibody Market Forecast to 2028 - COVID-19 Impact & Regional Analysis By Service ; Type ; Source ; Research Area ; End User

  • $ 3000
  • July 2021
  • 167 pages

The custom antibody market in Middle East and Africa is expected to grow from US$ 14.0 million in 2021 to US$ 25.0 million by 2028; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. Growing ...

  • Middle East
  • Africa
  • Pharmaceutical
  • Monoclonal Antibody
  • Industry analysis
  • Drug Approval
  • Health Expenditure

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on